利用甲福胺对心脏毒剂的心脏保护潜力
Ahmad Safari Maleki1,2, A Wallace Hayes3,4, Gholamreza Karimi5,6
1Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Naunyn-Schmiedeberg's archives of pharmacology
|June 16, 2025
概括
甲胺显示出对心脏损伤的显著心脏保护作用. 这种糖尿病药物通过减少氧化应激,炎症和调节细胞死亡途径来减轻心脏毒性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 心脏毒性会损害心脏功能,严重程度受年龄,暴露和病原体的影响.
- 甲福明是一种2型糖尿病药物,可改善胰岛素敏感性,降低葡萄糖的产生.
- 现有研究表明,甲胺具有心脏保护性质.
研究的目的:
- 审查科学文献关于甲福胺在预防心脏毒性的有效性.
- 阐明甲胺保护心脏免受毒性侮辱的机制.
主要方法:
- 在Web of Science,PubMed,Scopus和谷歌学者中进行全面的文献搜索.
- 包括到2025年4月发表的研究,使用相关的关键词.
- 对metformin对心脏毒性的影响进行识别的研究分析.
主要成果:
- 梅特福林通过多种途径减轻了心脏毒性.
- 关键的机制包括减少氧化应激和炎症.
- 甲福明还调节了AMPK酸化,NF-kB通路,自和亡.
结论:
- 甲胺对各种心脏毒剂具有潜在的心脏保护功效.
- 药物的多方面的机制有助于其心脏保护作用.
- 进一步强调了甲胺在控制心脏毒性的治疗潜力.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310
Heart Failure Drugs: Inotropic Agents
747
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
747
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
278
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
278
Heart Failure Drugs: Diuretics
505
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505


